Abstract: | A series of arylantimony ferrocenecarboxylates with the formula (C5H5FeC5H4CO2)nSbAr(5?n) (n = 1, 2; Ar = C6H5, 4‐CH3C6H4, 3‐CH3C6H4, 2‐CH3C6H4, 4‐ClC6H4, 4‐FC6H4) were synthesized and characterized by elemental analysis, IR, 1H NMR and mass spectra. The crystal structures of (C5H5FeC5H4CO2)2Sb(4‐CH3C6H4)3 and C5H5FeC5H4CO2SbPh4 were determined by X‐ray diffraction. Four human neoplastic cell lines (HL‐60, Bel‐7402, KB and Hela) were used to screen these compounds. The results indicate that these compounds at 10 µM show certain in vitro antitumor activities. Copyright © 2003 John Wiley & Sons, Ltd. |